| Shannon Lynn Knight, FNP-C | |
|
2100 N Main St # 304, Crown Point, IN 46307-1877 | |
| (574) 546-1900 | |
| (574) 546-1999 |
| Full Name | Shannon Lynn Knight |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 2100 N Main St # 304, Crown Point, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215550546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 28161216A (Indiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 28161216A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Rehab Consultants Llc | 7810184892 | 126 |
| Midwest Express Care 4 Llc | 4284909615 | 59 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago
| Entity Name | Neurology And Pain Management Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518900620 PECOS PAC ID: 4486676095 Enrollment ID: O20051223000201 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago
| Entity Name | Nwi Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043596703 PECOS PAC ID: 7618142977 Enrollment ID: O20111214000990 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago
| Entity Name | Integrated Rehab Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528379195 PECOS PAC ID: 7810184892 Enrollment ID: O20130507000096 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago
| Entity Name | Midwest Express Care 4 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629502810 PECOS PAC ID: 4284909615 Enrollment ID: O20180131001651 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago
| Entity Name | Aims-med, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881211878 PECOS PAC ID: 5597176263 Enrollment ID: O20201201003204 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Lynn Knight, FNP-C Po Box 10299, Fort Wayne, IN 46851-0299 Ph: (574) 546-1900 | Shannon Lynn Knight, FNP-C 2100 N Main St # 304, Crown Point, IN 46307-1877 Ph: (574) 546-1900 |
News Archive
In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.
When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago